GlaxoSmithKline (GSK) and The Wellcome Trust today announced a collaboration to develop a new class of antibacterial to combat the rise of certain drug-resistant hospital-acquired infections, including those that lead to pneumonia.
In 1928, Alexander Fleming opened the door to treating bacterial infections when he stumbled upon the first known antibiotic in a penicillium mold growing in a discarded experiment.
Scientists at The University of Nottingham have been awarded over ?366,000 to help unravel the mystery of a stomach bug which causes gastric ulcers and cancer. Their research could lead to the development of a vaccine for those most at risk.
The National Institutes of Health has awarded $7 million to a team of researchers from the University of Illinois and the University of Wisconsin to discover, engineer and produce a promising — yet little explored — class of antibiotic agents.
A surprising new theory developed at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska, suggests that some bacterial cells act as ?suicide bombers? in cell communities, with the altruistic intention of dying for the common good ? and in the process, strengthening other cells that then become resistant to antibiotic drugs.
Bird flu patients who get early treatment with the antiviral drug Tamiflu have the best chances of surviving while using steroids can do more harm than good, the World Health Organization (WHO) said.
Chronic cough ? often causing much discomfort, frustration, irritability and sleep disturbances in 10 percent to 20 percent of adults ? is one of the leading reasons for consultation with a physician according to a report published this month in Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).
An international network of researchers announced the release of a new web-based resource designed to facilitate the development of medicines to fight infectious diseases afflicting the developing world.
Based on a review of new and existing scientific evidence, most dental patients with heart disease do not need antibiotics before dental procedures to prevent infective endocarditis (IE), a rare, but life-threatening heart infection.
Researchers at the University of Pennsylvania School of Medicine have discovered that an enzyme produced by lung-infecting bacteria further shuts down a protein that is defective in cystic fibrosis patients.